Sigma receptor activation inhibits voltage-gated sodium channels in rat intracardiac ganglion neurons

International Journal of Physiology, Pathophysiology and Pharmacology

Volumn 2, Issue 1, 2010, Pages 1-11

  Zhang, Hongling ^a,b   Katnik, Christopher ^a   Cuevas, Javier ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Action potential; Intracardiac neurons; Parasympathetic; Sigma 1 receptor; Sodium channel

Indexed keywords

1,3 DI O TOLYLGUANIDINE; BD 1063; OPIATE AGONIST; OPIATE ANTAGONIST; PENTAZOCINE; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HEART NERVE; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; MEMBRANE STEADY POTENTIAL; NERVE CELL; NERVE CELL EXCITABILITY; NEWBORN; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; SODIUM CURRENT;

EID: 77953468563     PISSN: None     EISSN: 19448171     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Moravec J and Moravec M. Intrinsic nerve plexus of mammalian heart: morphological basis of cardiac rhythmical activity? Int Rev Cytol 1987; 106: 89-148.
2. Gagliardi M, Randall WC, Bieger D, Wurster RD, Hopkins DA and Armour JA. Activity of in vivo canine cardiac plexus neurons. Am J Physiol 1988; 255: H789-800.
3. Ardell JL. Structure and function of mammalian intrinsic cardiac neurons. In: Armour JAA, J.L., editors. In Neurocardiology. Oxford: Oxford University Press; 1994. p. 95-114.
4. Zhang H and Cuevas J. Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. J Neurophysiol 2002; 87: 2867-2879.
5. Zhang H and Cuevas J. Sigma receptor activation blocks potassium channels and depresses neuroexcitability in rat intracardiac neurons. J Pharmacol Exp Ther 2005; 313: 1387-1396.
6. Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, Su TP, Tam SW and Taylor DP. A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 1992; 13: 85-86.
7. Vilner BJ and Bowen WD. Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells. J Pharmacol Exp Ther 2000; 292: 900-911.
8. Bowen WD, Vilner BJ, Williams W, Bertha CM, Kuehne ME and Jacobson AE. Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinity. Eur J Pharmacol 1995; 279: R1-3.
9. Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E and Glossmann H. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci U S A 1996; 93: 8072-8077.
10. Senda T, Matsuno K, Okamoto K, Kobayashi T, Nakata K and Mita S. Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Eur J Pharmacol 1996; 315: 1-10.
11. Matsumoto RR, Hemstreet MK, Lai NL, Thurkauf A, De Costa BR, Rice KC, Hellewell SB, Bowen WD and Walker JM. Drug specificity of pharmacological dystonia. Pharmacol Biochem Behav 1990; 36: 151-155.
12. McCracken KA, Bowen WD and Matsumoto RR. Novel sigma receptor ligands attenuate the locomotor stimulatory effects of cocaine. Eur J Pharmacol 1999; 365: 35-38.
13. Ujike H, Kuroda S and Otsuki S. Sigma receptor antagonists block the development of sensitization to cocaine. Eur J Pharmacol 1996; 296: 123-128.
14. Snyder SH and Largent BL. Receptor mechanisms in antipsychotic drug action: focus on sigma receptors. J Neuropsychiatry Clin Neurosci 1989; 1: 7-15.
15. Novakova M, Ela C, Barg J, Vogel Z, Hasin Y and Eilam Y. Inotropic action of sigma receptor ligands in isolated cardiac myocytes from adult rats. Eur J Pharmacol 1995; 286: 19-30.
16. Lishmanov Yu B, Maslov LN, Naryzhnaya NV and Tam SW. Ligands for opioid and sigma-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress. Life Sci 1999; 65: PL13-17.
17. Novakova M, Bruderova V, Sulova Z, Kopacek J, Lacinova L, Kvetnansky R, Vasku A, Kaplan P, Krizanova O and Jurkovicova D. Modulation of expression of the sigma receptors in the heart of rat and mouse in normal and pathological conditions. Gen Physiol Biophys 2007; 26: 110-117.
18. Hille B. Ion Channels of Excitable Membranes. Sunderland, MA: Sinauer Associates, Inc., 2001.
19. Johannessen M, Ramachandran S, Riemer L, Ramos-Serrano A, Ruoho AE and Jackson MB. Voltage-gated sodium channel modulation by sigma-receptors in cardiac myocytes and heterologous systems. Am J Physiol Cell Physiol 2009; 296: C1049-1057.
20. Adams DJaC, J. Electrophysiological properties of cardiac neurons-the foundation of neurocardiology.. In: J.L.Ardell JAAa, editors. Basic and Clinical Neurocardiology. Oxford University Press; 2004. p. 1-60.
21. Cuevas J and Adams DJ. Local anaesthetic blockade of neuronal nicotinic ACh receptorchannels in rat parasympathetic ganglion cells. Br J Pharmacol 1994; 111: 663-672.
22. Cuevas J, Harper AA, Trequattrini C and Adams DJ. Passive and active membrane properties of isolated rat intracardiac neurons: regulation by H- and M-currents. J Neurophysiol 1997; 78: 1890-1902.
23. Locknar SA, Barstow KL, Tompkins JD, Merriam LA and Parsons RL. Calcium-induced calcium release regulates action potential generation in guinea-pig sympathetic neurones. J Physiol 2004; 555: 627-635.
24. Parsons RL, Barstow KL and Scornik FS. Spontaneous miniature hyperpolarizations affect threshold for action potential generation in mudpuppy cardiac neurons. J Neurophysiol 2002; 88: 1119-1127.
25. Hogg RC, Trequattrini C, Catacuzzeno L, Petris A, Franciolini F and Adams DJ. Mechanisms of verapamil inhibition of action potential firing in rat intracardiac ganglion neurons. J Pharmacol Exp Ther 1999; 289: 1502-1508.
26. Xu ZJ and Adams DJ. Voltage-dependent sodium and calcium currents in cultured parasympathetic neurones from rat intracardiac ganglia. J Physiol 1992; 456: 425-441.
27. Franciolini F, Hogg R, Catacuzzeno L, Petris A, Trequattrini C and Adams DJ. Large-conductance calcium-activated potassium channels in neonatal rat intracardiac ganglion neurons. Pflugers Arch 2001; 441: 629-638.
28. 2+ requirement, and regulation of M current. J Gen Physiol 2005; 126: 243-262.
29. Barstow KL, Locknar SA, Merriam LA and Parsons RL. The modulation of action potential generation by calcium-induced calcium release is enhanced by mitochondrial inhibitors in mudpuppy parasympathetic neurons. Neuroscience 2004; 124: 327-339.
30. DeHaven WI and Cuevas J. VPAC receptor modulation of neuroexcitability in intracardiac neurons: dependence on intracellular calcium mobilization and synergistic enhancement by PAC1 receptor activation. J Biol Chem 2004; 279: 40609-40621.
31. Soriani O, Vaudry H, Mei YA, Roman F and Cazin L. Sigma ligands stimulate the electrical activity of frog pituitary melanotrope cells through a G-protein-dependent inhibition of potassium conductances. J Pharmacol Exp Ther 1998; 286: 163-171.
32. Matsumoto RR, Bowen WD, Tom MA, Vo VN, Truong DD and De Costa BR. Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. Eur J Pharmacol 1995; 280: 301-310.
33. Hornchen U and Tauberger G. [Investigations on the mechanism of the effects of ketamine (Ketanest) on circulation and respiration (author's transl)]. Anaesthesist 1980; 29: 547-551.
34. Irnaten M, Wang J, Venkatesan P, Evans C, K. Chang KS, Andresen MC and Mendelowitz D. Ketamine inhibits presynaptic and postsynaptic nicotinic excitation of identified cardiac parasympathetic neurons in nucleus ambiguus. Anesthesiology 2002; 96: 667-674.
35. Narita M, Yoshizawa K, Aoki K, Takagi M, Miyatake M and Suzuki T. A putative sigma1 receptor antagonist NE-100 attenuates the discriminative stimulus effects of ketamine in rats. Addict Biol 2001; 6: 373-376.
36. Wu KM and Martin WR. Cardiovascular and respiratory effects of an opioid kappa agonist ethylketazocine and sigma agonist Nallylnormetazocine in acutely decerebrated dogs. Pharmacol Biochem Behav 1989; 34: 405-411.
37. Lishmanov Iu B, Maslov LN, Krylatov AV, Ugdyzhekova DS, Gilligan P and Tam SW. [The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands]. Eksp Klin Farmakol 2000; 63: 39-43.